Effect of four different oral contraceptives on various sex hormones and serum-binding globulins (Q44274326)

1 December 2017

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins (English)

1 reference

1 December 2017

Wiegratz I

1

1 reference

1 December 2017

Kutschera E

2

1 reference

1 December 2017

Lee JH

3

1 reference

1 December 2017

Moore C

4

1 reference

1 December 2017

Mellinger U

5

1 reference

1 December 2017

Winkler UH

6

1 reference

1 December 2017

Kuhl H

7

1 reference

1 December 2017

language of work or name

1 reference

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

67

1 reference

1 December 2017

1

1 reference

1 December 2017

25-32

1 reference

Oral contraceptives and myocardial infarction: results of the MICA case-control study

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Influence of endometrial 17 beta-hydroxysteroid dehydrogenase activity on the binding of estradiol to receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Validity of radioimmunological methods for determining free testosterone in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Oral contraceptive containing natural estradiol for premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Endometrial vascular changes and bleeding disturbances with long-acting progestins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Clinical and hormonal effects of two contraceptives: Correlation to serum concentrations of levonorgestrel and gestodene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Changes in androgens during treatment with four low-dose contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Serum Concentrations of Ethinylestradiol, 3-Keto-Desogestrel, SHBG, CBG and Gonadotropins during Treatment with a Biphasic Oral Contraceptive Containing Desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels i

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Is the contraceptive effect of 300 micrograms of norethisterone mainly peripheral or central?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Oral contraceptive agents do not affect serum prolactin in normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Effects of oral contraceptive steroids on pituitary prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

Elevation of serum prolactin during application of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900436-5

10.1016/S0010-7824(02)00436-5

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference